nivolumab plus ipilimumab shows clinical benefit as first-line treatment for centrally confirmed...
Published 10 days ago • 26 plays • Length 3:48Download video MP4
Download video MP3
Similar videos
-
2:44
cancer immunotherapy with nivolumab plus ipilimumab vs. chemotherapy: insights from checkmate 227
-
5:22
checkmate 743: first-line nivolumab plus ipilimumab vs chemotherapy in patients with unresectabl...
-
3:14
comment: nivolumab plus ipilimumab combination for advanced nsclc
-
5:52
nivolumab and salvage nivolumab plus ipilimumab for arcc
-
5:19
fraction-rcc: evaluating nivolumab plus ipilimumab in patients with treatment-refractory advance...
-
2:48
checkmate067 outcomes: nivolumab plus ipilimumab in advanced melanoma
-
9:09
nivolumab with alternatively scheduled ipilimumab in first-line treatment of advanced rcc
-
4:50
ipilimumab/nivolumab in first-line mrcc
-
1:13
checkmate 067: nivolumab plus ipilimumab combination therapy in advanced melanoma
-
8:45
nivolumab ipilimumab vs platinum-doublet chemotherapy as first-line treatment for advanced nsclc
-
6:21
checkmate 459: safety and efficacy of nivolumab versus sorafenib as a first-line treatment in ad...
-
6:51
success for ipilimumab and nivolumab combo in advanced melanoma
-
11:58
checkmate 214: nivolumab ipilimumab or sunitinib in patients with advanced renal cell carcinoma
-
5:18
neoadjuvant ipilimumab and nivolumab immunotherapy for resectable stage iii melanoma
-
8:28
success for ipilimumab and nivolumab combo in advanced melanoma
-
6:24
initial nivolumab-based treatment halts melanoma progression
-
3:16
first-line nivolumab ipilimumab in metastatic uveal melanoma
-
3:46
nivolumab and ipilimumab for metastatic sarcoma
-
6:16
treatment-free survival results of nivolumab and salvage nivolumab ipilimumab for accrcc